This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- ↵* Corresponding author; email: lschulz2{at}uwhealth.org
Abstract
Infections resistant to many or all antimicrobials are occurring globally, nationally, and locally. Resistance is mediated through common, and often communicable, mechanisms and has eliminated many antibiotics from the treatment armamentarium. New antimicrobial agents have been developed to address new resistance mechanisms. Effectively combating antimicrobial resistance requires that we recognize its complex and extensive impact, encourage and legislate for new antimicrobial development, and establish treatment strategies for infections caused by antimicrobial resistant pathogens.
- Received May 18, 2018.
- Accepted May 22, 2018.
- Published by American Society for Clinical Laboratory Science